Precision Medicine Market Strategic Outlook to 2025 - Bristol-Myers Squibb Company, Eli Lilly and Company, QIAGEN, Teva Pharmaceutical Industries Ltd., Pfizer, F. Hoffmann-La Roche Ltd, Illumina, Inc., Quest Diagnostics Incorporated., Novartis AG

“Precision Medicine Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global precision medicine market based on technology, and application. It also provides market size and forecast till 2025 for overall precision medicine market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

Get Sample Overview at https://www.theinsightpartners.com/sample/TIPBT00002184

Precision medicine is used to characterizing the diseases and detailed study on patient specific information to diagnose. The concept based on rapidly growing in the medical community through expansions in advanced technologies including molecular biomarker analysis, next generation sequencing, bioinformatics and big data analytics. Precision medicine helps to make possible the diagnosis and treatment of various diseases by relying on genomics and specific biomarker techniques. The approach allows researchers and doctors to predict more accurately the treatment and prevention strategies for a particular disease.

The precision medicine market is anticipated to grow with a significant rate in the coming years, owing to factors such as, growing prevalence of cancer, rising adoption of gene therapy to reduce cost burden for such diseases will favors industry expansion. On other hand, the availability of large-scale human genome databases coupled with computational tools are anticipated to provide more growth opportunities for precision medicine market in the forecast period.

The "Global Precision Medicine Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global precision medicine market with detailed market segmentation by technology, application, and geography. The global precision medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The global precision medicine market is segmented on the basis of technology, and application. The precision medicine market is segmented into drug discovery, companion diagnostics, sequencing, bio-informatics and big data analytics. Based on application, the precision medicine market is classified as, oncology, respiratory, CNS, infectious disease, immunology, cardiology and others.

North America is leading the precision medicine market owing to increasing investment in the field of precision medicine in US, increasing adoption to leading edge technologies coupled with a favorable legal environment created through grants and initiatives by the government are the factors that help to drive the market in the region. However, the Asia-Pacific region is expected to witness significant growth due to rising adoption of gene sequencing and big data analytics, increasing government initiatives and investment in R&D for novel biomarkers used to treat cancer and rapidly growing healthcare expenditure in emerging economies will augment industry size in the region.

Companies mentioned in this report are-
1. F. Hoffmann-La Roche Ltd
2. Illumina, Inc.
3. Quest Diagnostics Incorporated.
4. Novartis AG
5. Bristol-Myers Squibb Company
6. Eli Lilly and Company
7. QIAGEN
8. Teva Pharmaceutical Industries Ltd.
9. Pfizer Inc.
10. IBM

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key precision medicine manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Access Complete Report at https://www.theinsightpartners.com/buy/TIPBT00002184

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.